COVID-19 and the Economics of Vaccine Development

Intervention by the United States government helped the rapid development and large scale production of three COVID-19 vaccines. What were the economic, legal, and political challenges of developing and distributing vaccines in the face of an emerging deadly pandemic? How were these challenges addressed? And what were the successes and shortcomings of these policies? To discuss these issues, EconoFact Chats welcomes back Chad Bown of the Peterson Institute for International Economics.

 

Chad is the Reginald Jones Senior Fellow at the Peterson Institute for International Economics in Washington, D.C., and the host of the podcast Trade Talks that focuses on international trade and its attendant policies.